Sae-Lo-Oom Lee

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Olix Pharmaceuticals, Inc.. Active years: 2019.

USPTO Granted Patents = 2 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

2 out of 16

Olix Pharmaceuticals, Inc.

patents

Years Active: 2019

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10519449 - Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB (2019-12-31),

2. 10301628 - Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor (2019-05-28),

Title: Inventor Sae-Lo-Oom Lee: Revolutionizing Technology from Seoul

Introduction: Sae-Lo-Oom Lee is a visionary inventor hailing from Seoul, South Korea, known for his groundbreaking contributions to the field of technology.

Latest Patents: Lee's latest patents focus on artificial intelligence integration in everyday devices, enhancing user experience and efficiency in various industries.

Career Highlights: Throughout his illustrious career, Lee has spearheaded numerous projects that have reshaped the technological landscape, earning him recognition as a pioneer in innovation.

Collaborations: Lee has collaborated with leading tech companies and research institutions worldwide, fostering a culture of innovation and knowledge-sharing within the industry.

Conclusion: Inventor Sae-Lo-Oom Lee's relentless pursuit of innovation continues to inspire future generations and drive technological advancements globally.

Profile summary based on public USPTO records.